<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40869571</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>16</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease-Long-Term Outcomes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5747</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14165747</ELocationID><Abstract><AbstractText><b>Background</b>: The optimal revascularization strategy for patients with left main coronary artery (LMCA) disease has been repeatedly addressed in randomized controlled trials (RCTs), although outcomes from real-life clinical studies are still poorly investigated. <b>Objectives</b>: This retrospective study aimed to assess the complete 5-year outcomes for individuals with multivessel coronary artery disease (MVD) involving LMCA disease treated with coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) as recommended by a local HT. <b>Methods</b>: From 2016 to 2019, 176 Heart Team (HT) meetings were held. Primary and secondary endpoints of 267 patients with MVD involving LMCA disease qualified either for CABG or PCI (109 and 158 patients, respectively) with subsequent optimal medical therapy (OMT) were assessed. The primary endpoint of the study was as an overall mortality, while secondary endpoints contained major adverse cardiac and cerebrovascular events (MACCE)-specifically, stroke, myocardial infarction (MI), repeat revascularization (RR), and the individual components of MACCE. <b>Results</b>: At 5 years, we found no significant difference in overall mortality between the both cohorts (22.9%-CABG vs. 24.7%-PCI, <i>p</i> = 0.74). The rate of MI was higher in patients treated percutaneously (7.3% vs. 15.8% for PCI, <i>p</i> = 0.04), while the incidence of stroke was higher in patients who underwent CABG (3.8% vs. 11.0% for CABG, <i>p</i> = 0.02). A MACCE occurrence was higher in PCI cohort (77.2% vs. 55.0%, <i>p</i> &lt; 0.001), mainly driven by higher rates of RR was higher in patients treated percutaneously (32.9% vs. 13.8%, <i>p</i> &lt; 0.001). <b>Conclusions:</b> For patients with LMCA disease, neither CABG nor PCI following HT decisions showed overwhelming superiority in real-life clinical practice: occurrence of all-cause death was similar, rates of MACCE, MI, and repeat revascularization advocated CABG, while incidence of strokes favored PCI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jonik</LastName><ForeName>Szymon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gumi&#x119;&#x17c;na</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baru&#x15b;</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilimski</LastName><ForeName>Rados&#x142;aw</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Heart, Thorax Surgery and Transplantology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ku&#x15b;mierczyk</LastName><ForeName>Mariusz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0003-9665-7129</Identifier><AffiliationInfo><Affiliation>Department of Heart, Thorax Surgery and Transplantology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opolski</LastName><ForeName>Grzegorz</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grabowski</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kochman</LastName><ForeName>Janusz</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huczek</LastName><ForeName>Zenon</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazurek</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Heart Team</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">left main coronary artery disease</Keyword><Keyword MajorTopicYN="N">multivessel coronary artery disease</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40869571</ArticleId><ArticleId IdType="pmc">PMC12387798</ArticleId><ArticleId IdType="doi">10.3390/jcm14165747</ArticleId><ArticleId IdType="pii">jcm14165747</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collet C., Capodanno D., Onuma Y., Banning A., Stone G.W., Taggart D.P., Sabik J., Serruys P.W. Left main coronary artery disease: Pathophysiology, diagnosis, and treatment. Nat. Rev. Cardiol. 2018;15:321&#x2013;331. doi: 10.1038/s41569-018-0001-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0001-4</ArticleId><ArticleId IdType="pubmed">29599504</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ascenzo F., Presutti D.G., Picardi E., Moretti C., Omed&#xe8; P., Sciuto F., Novara M., Yan A.T., Goodman S., Mahajan N., et al. Prevalence and non-invasive predictors of left main or three-vessel coronary disease: Evidence from a collaborative international meta-analysis including 22,740 patients. Heart. 2012;98:914&#x2013;919. doi: 10.1136/heartjnl-2011-301596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2011-301596</ArticleId><ArticleId IdType="pubmed">22626899</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., A Byrne R., Collet J.-P., Falk V., Head S.J., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019;40:87&#x2013;165. doi: 10.1093/eurheartj/ehy394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy394</ArticleId><ArticleId IdType="pubmed">30165437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoole S.P., Bambrough P. Recent advances in percutaneous coronary intervention. Heart. 2020;106:1380&#x2013;1386. doi: 10.1136/heartjnl-2019-315707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2019-315707</ArticleId><ArticleId IdType="pubmed">32522821</ArticleId></ArticleIdList></Reference><Reference><Citation>Spirito A., Cangialosi P., Cao D., Nicolas J., Mehran R. Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention. Interv. Cardiol. Clin. 2022;11:419&#x2013;428. doi: 10.1016/j.iccl.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iccl.2022.02.003</ArticleId><ArticleId IdType="pubmed">36243487</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone G.W., Kappetein A.P., Sabik J.F., Pocock S.J., Morice M.-C., Puskas J., Kandzari D.E., Karmpaliotis D., Brown W.M., Lembo N.J., et al. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N. Engl. J. Med. 2019;381:1820&#x2013;1830. doi: 10.1056/NEJMoa1909406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1909406</ArticleId><ArticleId IdType="pubmed">31562798</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Serruys P.W., Gao C., Hara H., Takahashi K., Ono M., Kawashima H., O&#x2019;lEary N., Holmes D.R., Witkowski A., et al. Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease. Eur. Heart J. 2021;43:56&#x2013;67. doi: 10.1093/eurheartj/ehab441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab441</ArticleId><ArticleId IdType="pmc">PMC8720143</ArticleId><ArticleId IdType="pubmed">34405232</ArticleId></ArticleIdList></Reference><Reference><Citation>Park D.W., Ahn J.M., Park H., Yun S.C., Kang D.Y., Lee P.H., Kim Y.H., Lim D.S., Rha S.W., Park G.M., et al. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial. Circulation. 2020;141:1437&#x2013;1446. doi: 10.1161/CIRCULATIONAHA.120.046039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.046039</ArticleId><ArticleId IdType="pubmed">32223567</ArticleId></ArticleIdList></Reference><Reference><Citation>Thuijs D., Kappetein A.P., Serruys P.W., Mohr F.-W., Morice M.-C., Curzen N., Davierwala P., Noack T., Milojevic M., Dawkins K.D., et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019;394:1325&#x2013;1334. doi: 10.1016/S0140-6736(19)31997-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31997-X</ArticleId><ArticleId IdType="pubmed">31488373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo M., Blitzer D., Laforgia P.L., Doulamis I.P., Perrin N., Bortolussi G., Guariento A., Putzu A. Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis. J. Thorac. Cardiovasc. Surg. 2022;163:94&#x2013;105.e15. doi: 10.1016/j.jtcvs.2020.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.04.010</ArticleId><ArticleId IdType="pubmed">32499076</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H., Shiomi H., Morimoto T., Furukawa Y., Nakagawa Y., Ando K., Kadota K., Tazaki J., Natsuaki M., Minatoya K., et al. Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2) Catheter. Cardiovasc. Interv. 2020;96:42&#x2013;51. doi: 10.1002/ccd.28420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.28420</ArticleId><ArticleId IdType="pubmed">31389659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam D.Y., Fang J., Rocha R.V., Rao S.V., Dzavik V., Lawton J., Austin P.C., Gaudino M., Fremes S.E., Lee D.S. Real-World Examination of Revascularization Strategies for Left Main Coronary Disease in Ontario, Canada. JACC Cardiovasc. Interv. 2023;16:277&#x2013;288. doi: 10.1016/j.jcin.2022.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2022.10.016</ArticleId><ArticleId IdType="pubmed">36609048</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmerini T., Serruys P., Kappetein A.P., Genereux P., Della Riva D., Reggiani L.B., Christiansen E.H., Holm N.R., Thuesen L., Makikallio T., et al. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. Am. Heart J. 2017;190:54&#x2013;63. doi: 10.1016/j.ahj.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2017.05.005</ArticleId><ArticleId IdType="pubmed">28760214</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatine M.S., Bergmark B.A., Murphy S.A., O&#x2019;GAra P.T., Smith P.K., Serruys P.W., Kappetein A.P., Park S.-J., Park D.-W., Christiansen E.H., et al. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: An individual patient data meta-analysis. Lancet. 2021;398:2247&#x2013;2257. doi: 10.1016/S0140-6736(21)02334-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02334-5</ArticleId><ArticleId IdType="pubmed">34793745</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron S.J., Chinnakondepalli K., Magnuson E.A., Kandzari D.E., Puskas J.D., Ben-Yehuda O., van Es G.A., Taggart D.P., Morice M.C., Lembo N.J., et al. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial. J. Am. Coll. Cardiol. 2017;70:3113&#x2013;3122. doi: 10.1016/j.jacc.2017.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.10.036</ArticleId><ArticleId IdType="pubmed">29097293</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm N.R., Makikallio T., Lindsay M.M., Spence M.S., Erglis A., A Menown I.B., Trovik T., Kalinauskas G., Mogensen L.J.H., Nielsen P.H., et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: Updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet. 2020;395:191&#x2013;199. doi: 10.1016/S0140-6736(19)32972-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32972-1</ArticleId><ArticleId IdType="pubmed">31879028</ArticleId></ArticleIdList></Reference><Reference><Citation>Laukkanen J.A., Kunutsor S.K., Niemela M., Kervinen K., Thuesen L., M&#xe4;kikallio T.H. All-cause mortality and major cardiovascular outcomes comparing percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: A meta-analysis of short-term and long-term randomised trials. Open Heart. 2017;4:e000638. doi: 10.1136/openhrt-2017-000638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2017-000638</ArticleId><ArticleId IdType="pmc">PMC5729300</ArticleId><ArticleId IdType="pubmed">29259788</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore S., Guo Y., Samadashvili Z., Blecker S., Xu J., Hannan E.L. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N. Engl. J. Med. 2015;372:1213&#x2013;1222. doi: 10.1056/NEJMoa1412168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1412168</ArticleId><ArticleId IdType="pubmed">25775087</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone G.W., Sabik J.F., Serruys P.W., Simonton C.A., G&#xe9;n&#xe9;reux P., Puskas J., Kandzari D.E., Morice M.-C., Lembo N., Brown W.M.I., et al. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N. Engl. J. Med. 2016;375:2223&#x2013;2235. doi: 10.1056/NEJMoa1610227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1610227</ArticleId><ArticleId IdType="pubmed">27797291</ArticleId></ArticleIdList></Reference><Reference><Citation>Milojevic M., Head S.J., Parasca C.A., Serruys P.W., Mohr F.W., Morice M.C., Mack M.J., St&#xe5;hle E., Feldman T.E., Dawkins K.D., et al. Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX. J. Am. Coll. Cardiol. 2016;67:42&#x2013;55. doi: 10.1016/j.jacc.2015.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.10.043</ArticleId><ArticleId IdType="pubmed">26764065</ArticleId></ArticleIdList></Reference><Reference><Citation>Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., St&#xe5;hle E., Feldman T.E., Van Den Brand M., Bass E.J., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009;360:961&#x2013;972. doi: 10.1056/NEJMoa0804626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0804626</ArticleId><ArticleId IdType="pubmed">19228612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J.M., Roh J.H., Kim Y.H., Park D.W., Yun S.C., Lee P.H., Chang M., Park H.W., Lee S.W., Lee C.W., et al. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study. J. Am. Coll. Cardiol. 2015;65:2198&#x2013;2206. doi: 10.1016/j.jacc.2015.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.03.033</ArticleId><ArticleId IdType="pubmed">25787197</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlofmitz E., Genereux P., Chen S., Dressler O., Ben-Yehuda O., Morice M.-C., Puskas J.D., Taggart D.P., Kandzari D.E., Crowley A., et al. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score. Circ. Cardiovasc. Interv. 2019;12:e008007. doi: 10.1161/CIRCINTERVENTIONS.118.008007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.118.008007</ArticleId><ArticleId IdType="pubmed">31495220</ArticleId></ArticleIdList></Reference><Reference><Citation>Head S.J., Milojevic M., Daemen J., Ahn J.-M., Boersma E., Christiansen E.H., Domanski M.J., E Farkouh M., Flather M., Fuster V., et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: A pooled analysis of individual patient data. Lancet. 2018;391:939&#x2013;948. doi: 10.1016/S0140-6736(18)30423-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30423-9</ArticleId><ArticleId IdType="pubmed">29478841</ArticleId></ArticleIdList></Reference><Reference><Citation>Park D.W., Ahn J.M., Yun S.C., Yoon Y.-H., Kang D.-Y., Lee P.H., Lee S.-W., Park S.-W., Seung K.B., Gwon H.-C., et al. 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease. J. Am. Coll. Cardiol. 2018;72:2813&#x2013;2822. doi: 10.1016/j.jacc.2018.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.09.012</ArticleId><ArticleId IdType="pubmed">30261236</ArticleId></ArticleIdList></Reference><Reference><Citation>Paszek E., Zajdel W., Musialek P., Soko&#x142;owski A., Guzik B., Kab&#x142;ak-Ziembicka A., Niewiara &#x141;., Pankowska M., Mielimonka A., &#x17b;mudka K. Percutaneous management of long and diffused coronary lesions using newer generation drug-eluting stents in routine clinical practice: Long-term outcomes and complication predictors. Pol. Arch. Intern. Med. 2019;129:392&#x2013;398. doi: 10.20452/pamw.14864.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.14864</ArticleId><ArticleId IdType="pubmed">31169263</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasca C.A., Head S.J., Milojevic M., Mack M.J., Serruys P.W., Morice M.C., Mohr F.W., Feldman T.E., Colombo A., Dawkins K.D., et al. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years. JACC Cardiovasc. Interv. 2016;9:2493&#x2013;2507. doi: 10.1016/j.jcin.2016.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2016.09.044</ArticleId><ArticleId IdType="pubmed">28007201</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonik S., Marchel M., Pedzich-Placha E., Pietrasik A., Rdzanek A., Huczek Z., Kochman J., Budnik M., Pi&#x105;tkowski R., Scis&#x142;o P., et al. Optimal Management of Patients with Severe Coronary Artery Disease following Multidisciplinary Heart Team Approach-Insights from Tertiary Cardiovascular Care Center. Int. J. Environ. Res. Public Health. 2022;19:3933. doi: 10.3390/ijerph19073933.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19073933</ArticleId><ArticleId IdType="pmc">PMC8997622</ArticleId><ArticleId IdType="pubmed">35409613</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka A., Giustino G., Briede I., Sawaya F.J., Daemen J., Kawamoto H., Meliga E., D&#x2019;AScenzo F., Cerrato E., Stefanini G.G., et al. New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry. Int. J. Cardiol. 2019;280:30&#x2013;37. doi: 10.1016/j.ijcard.2018.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2018.12.003</ArticleId><ArticleId IdType="pubmed">30595357</ArticleId></ArticleIdList></Reference><Reference><Citation>Head S.J., Kaul S., Mack M.J., Serruys P.W., Taggart D.P., Holmes D.R., Leon M.B., Marco J., Bogers A.J.J.C., Kappetein A.P. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur. Heart J. 2013;34:2510&#x2013;2518. doi: 10.1093/eurheartj/eht059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht059</ArticleId><ArticleId IdType="pubmed">23425523</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G., Serruys P.W., Sabik J.F., 3rd, Mehran R., Maehara A., Puskas J.D., Simonton C.A., Lembo N.J., Kandzari D.E., Morice M.C., et al. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial. JACC Cardiovasc. Interv. 2020;13:375&#x2013;387. doi: 10.1016/j.jcin.2019.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2019.09.019</ArticleId><ArticleId IdType="pubmed">31954680</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadafora L., Pastena P., Cacciatore S., Betti M., Biondi-Zoccai G., D&#x2019;aScenzo F., De Ferrari G.M., De Filippo O., Versaci F., Sciarretta S., et al. One-Year Prognostic Differences and Management Strategies between ST-Elevation and Non-ST-Elevation Myocardial Infarction: Insights from the PRAISE Registry. Am. J. Cardiovasc. Drugs. 2025 doi: 10.1007/s40256-025-00739-8. Online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40256-025-00739-8</ArticleId><ArticleId IdType="pubmed">40555879</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrahman M., Alsabbagh A., Kuntze T., Lauer B., Ohlow M.A. Impact of Hierarchy on Multidisciplinary Heart-Team Recommendations in Patients with Isolated Multivessel Coronary Artery Disease. J. Clin. Med. 2019;8:1490. doi: 10.3390/jcm8091490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8091490</ArticleId><ArticleId IdType="pmc">PMC6780608</ArticleId><ArticleId IdType="pubmed">31546762</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>